Clinical trials
Phase 3 Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 5 |
| Unknown status | 2 |
| Withdrawn | 1 |
| Recruiting | 1 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blue Earth Diagnostics | 3 |
| Eisai Inc. | 3 |
| Brigham and Women's Hospital | 2 |
| Eli Lilly and Company | 2 |
| Lyra Therapeutics | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| Xenon Pharmaceuticals Inc. | 2 |
| Alseres Pharmaceuticals, Inc | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Eleven Biotherapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disease | 29 |
| Prostatic Neoplasms | 4 |
| Nervous System Diseases | 3 |
| Amyloid Neuropathies, Familial | 2 |
| Amyloidosis | 2 |
| Brain Diseases | 2 |
| Central Nervous System Diseases | 2 |
| Epilepsy | 2 |
| Epileptic Syndromes | 2 |
| Gastroesophageal Reflux | 2 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.